Stayble Therapeutics Company

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain triggered by degenerative changes in the disc. Stayble’s treatment has the potential to offer a solution that may alleviate or abolish the pain without the need for surgery Behind Stayble Therapeutics stands an experienced, multidisciplinary team including a world-renowned back-pain researcher, experienced bio-entrepreneurs and former big pharma senior management. Their vision is that this treatment concept will reach out to millions of patients who are disabled by chronic back pain. We believe this drug has the potential to drastically reduce the suffering from a widespread, incapacitating condition.
Technology: Others
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Göteborg, Vastra Gotaland, Sweden
Founded Date: 2012-01-01
Employees Number: 1-10
Investors Number: 1
Total Funding: $6M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership